Investigating Vector-Borne Determinants of Aedes Transmitted Arboviral Infections in Cambodia: An Observational Longitudinal Cohort Study in Children
NCT03534245 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 775
Last updated 2026-05-22
Summary
Background:
Some mosquitos carry viruses that can cause disease. Some examples are dengue and Zika. The mosquitos spread disease by biting people and infecting them with the virus. Children, elderly people, and people who are already sick are especially likely to get infected. Researchers want to learn more to help make new medicines to treat these viral infections.
Objective:
To learn more about how mosquitos infect people, and why young children are more likely to get sick than other people.
Eligibility:
Healthy children 2-9 years old who live near the study site. This is Kampong Speu District Referral Hospital in Chbar Mon, Cambodia.
Design:
At visit 1, participants will have a physical exam. A small amount of blood will be taken from their arm or finger. Parents will answer questions about the participant s general health and medical history.
Participants will come back to the study site every wet season and every dry season for the next 3 years. The visits will be the same as visit 1 and take about 1 hour.
If at any time during the study the participant gets a fever and has other symptoms that could be caused by these viral diseases, they should be brought to the study site. These symptoms might include headache, pain behind the eyes, muscle pain, or joint pain. They can also include a rash that lasts longer than 12 hours.
Participation ends after the final study visit in late 2021.
...
Conditions
- Dengue Fever
Sponsors & Collaborators
-
National Institute of Allergy and Infectious Diseases (NIAID)
lead NIH
Principal Investigators
-
Luiz F Oliveira, M.D. · National Institute of Allergy and Infectious Diseases (NIAID)
Eligibility
- Min Age
- 2 Years
- Max Age
- 9 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-07-01
- Primary Completion
- 2022-01-25
- Completion
- 2022-01-25
Countries
- Cambodia
More Related Trials
-
Study of a Tetravalent Dengue Vaccine in Healthy Children Aged 2 to 11 Years in Malaysia
NCT01254422 ·Status: COMPLETED ·Phase: PHASE3
-
Spatial Repellents for Aedes-borne Virus Control in Sri Lanka
NCT05452447 ·Status: COMPLETED ·Phase: NA
-
Clinical Study to Assess Minimum Mosquito Bites for P. Vivax Infection in Thai Adults
NCT07257965 ·Status: RECRUITING ·Phase: NA
-
Sustainable Reduction of Dengue in Colombia: Vector Breeding Site Intervention With an Insecticidal Coating
NCT06268691 ·Status: COMPLETED ·Phase: NA
-
Defining Skin Immunity of a Bite of Key Insect Vectors in Humans
NCT03641339 ·Status: COMPLETED ·Phase: NA
-
Impact of Project Wolbachia - Singapore on Dengue Incidence
NCT05505682 ·Status: COMPLETED ·Phase: NA
-
Impact of Wolbachia Deployment on Arboviral Disease Incidence in Medellin and Bello, Colombia
NCT03631719 ·Status: COMPLETED
-
Characterizing Humoral Immune Response to Mosquito Bites
NCT04478370 ·Status: COMPLETED ·Phase: NA
-
Cohort of Patients Infected by an Arbovirus
NCT01099852 ·Status: UNKNOWN
-
Phase III Trial to Evaluate Efficacy and Safety of a Tetravalent Dengue Vaccine
NCT02406729 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Immuno-epidemiological and Socio-behavioral Evaluation of Release of Sterile Male Aedes Albopictus Mosquitoes on Human-vector Contacts
NCT05313126 ·Status: UNKNOWN ·Phase: NA
-
Factors Associated With Hospitalization and Severity of Arbovirosis in the Indian Ocean
NCT07119086 ·Status: RECRUITING ·Phase: NA
-
Phase I Study of Safety and Immunogenicity of AMA1-C1Alhydrogel + CPG 7909 Vaccine for Malaria
NCT00414336 ·Status: COMPLETED ·Phase: PHASE1
-
Malaria Vaccine for Children in Mali
NCT00740090 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluating the Safety and Immunogenicity of AGS-v PLUS, a Universal Mosquito-Borne Disease and Mosquito Control Vaccine
NCT04009824 ·Status: COMPLETED ·Phase: PHASE1
-
Implementation Research of New Dengue Vector Control Tools
NCT00883441 ·Status: COMPLETED ·Phase: NA
-
A Study of Dengue Vaccine in Healthy Children, Teenagers and Adults in India
NCT06060067 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Assess the Immunogenicity, Tolerability and Safety of a Malaria Vaccine and Also Its Protective Efficacy in a Malaria Challenge Model
NCT01397227 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Effect of Ivermectin Metabolites on Mosquito Survival
NCT03690453 ·Status: COMPLETED ·Phase: PHASE4
-
Platform Study to Evaluate the Efficacy and Safety of Anti-malarial Agents in Participants With Uncomplicated Plasmodium Falciparum Malaria
NCT07235020 ·Status: COMPLETED ·Phase: PHASE2
-
Experimental Vaccine for Malaria in Adults in Mali
NCT00343005 ·Status: COMPLETED ·Phase: PHASE1
-
Experimental Vaccine for Plasmodium Falciparum Malaria
NCT00340431 ·Status: COMPLETED ·Phase: PHASE1
-
Initial Study of Malaria Vaccine Pfs25-EPA/Alhydrogel(Registered Trademark)
NCT01434381 ·Status: COMPLETED ·Phase: PHASE1
-
A Cluster-randomized Trial to EValuate the Efficacy of Wolbachia-InfecTed Aedes Aegypti Mosquitoes in Reducing the Incidence of Arboviral Infection in Brazil (EVITA Dengue)
NCT04514107 ·Status: COMPLETED ·Phase: NA
-
World Mosquito Program Noumea - Human Sample Component
NCT03552094 ·Status: UNKNOWN